BECKMAN BETA-2-MICROGLOBULIN (B2M)

BECKMAN BETA-2-MICROGLOBULIN (B2M) is an FDA 510(k)-cleared medical device (K940353) manufactured by Beckman Instruments, Inc.. This device is classified under the Immunology specialty. FDA Device Class II (Special Controls) — moderate risk, requires 510(k) clearance. FDA clearance granted on April 20, 1994. Regulation: 8.